Page 29 - Johnson Medtech News Today

Along with Johnson & Johnson, Boston Scientific, and Medtronic were also among the winners at this year’s Irish Medtech Awards.

From pulsed-field ablation to non-invasive monitoring, this was an exciting year for cardiac device tech. Here are MassDevice's top stories.

Broadens MedTech portfolio with world leading solutions for heart recovery

Johnson & Johnson (NYSE:JNJ) announced today that it completed its $16.6 billion acquisition of Abiomed (Nasdaq:ABMD).

Johnson & Johnson completed its previously announced $16.6 billion acquisition of medical tech company Abiomed on Dec. 22.

Abiomed (Nasdaq:ABMD) announced today that the FDA approved the version of Impella ECP for its upcoming pivotal trial.

Johnson & Johnson announced today that it extended the expiration date of its offer to acquire Abiomed.

/PRNewswire/ -- Colleen Flesher, currently COO Movora, has been appointed new Co-CEO of veterinary MedTech leader Movora, an operating company of Vimian....

RIYADH: Johnson & Johnson, the global medical technology provider, is providing digital solutions that will shorten the time spent by patients in hospitals. According to Marzena Kulis, managing director of Johnson & Johnson MedTech Middle East, the move is crucial in countries with lower bed capacity. “The digital solutions that we currently offer help to shorten the time of

A new report, including insights from international experts, reveals that Atrial Fibrillation diagnosis is more challenging in women, needing a tailored management approach SINGAPORE, Nov. 17, 2022 /PRNewswire/ -- Biosense Webster, Inc., part of Johnson & Johnson MedTech[], today announced the release of a report titled, 'Atrial Fibrillation Exacts Toll on Women: Addressing the Gender Disparity in the Treatment and Management of Atrial Fibrillation in the Asia-Pacific Region'. Endors...